These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20925138)

  • 1. Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer.
    Montanaro L
    J Pathol; 2010 Dec; 222(4):345-9. PubMed ID: 20925138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
    Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
    Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
    Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
    PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects in mTR stability and telomerase activity produced by the Dkc1 A353V mutation in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB domain.
    Machado-Pinilla R; Carrillo J; Manguan-Garcia C; Sastre L; Mentzer A; Gu BW; Mason PJ; Perona R
    Clin Transl Oncol; 2012 Oct; 14(10):755-63. PubMed ID: 22855157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance.
    Garus A; Autexier C
    RNA; 2021 Dec; 27(12):1441-1458. PubMed ID: 34556550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.
    Brault ME; Lauzon C; Autexier C
    Hum Mol Genet; 2013 Sep; 22(17):3498-507. PubMed ID: 23660516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene structure and expression of the mouse dyskeratosis congenita gene, dkc1.
    Heiss NS; Bächner D; Salowsky R; Kolb A; Kioschis P; Poustka A
    Genomics; 2000 Jul; 67(2):153-63. PubMed ID: 10903840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyskeratosis congenita and telomerase.
    Bessler M; Wilson DB; Mason PJ
    Curr Opin Pediatr; 2004 Feb; 16(1):23-8. PubMed ID: 14758110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A telomerase component is defective in the human disease dyskeratosis congenita.
    Mitchell JR; Wood E; Collins K
    Nature; 1999 Dec; 402(6761):551-5. PubMed ID: 10591218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing.
    Mochizuki Y; He J; Kulkarni S; Bessler M; Mason PJ
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10756-61. PubMed ID: 15240872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer.
    Montanaro L; Brigotti M; Clohessy J; Barbieri S; Ceccarelli C; Santini D; Taffurelli M; Calienni M; Teruya-Feldstein J; Trerè D; Pandolfi PP; Derenzini M
    J Pathol; 2006 Sep; 210(1):10-8. PubMed ID: 16841302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
    Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE
    Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation.
    Montanaro L; Calienni M; Bertoni S; Rocchi L; Sansone P; Storci G; Santini D; Ceccarelli C; Taffurelli M; Carnicelli D; Brigotti M; Bonafè M; Treré D; Derenzini M
    Cancer Res; 2010 Jun; 70(11):4767-77. PubMed ID: 20501855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyskeratosis congenita: a genetic disorder of many faces.
    Kirwan M; Dokal I
    Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita.
    Parry EM; Alder JK; Lee SS; Phillips JA; Loyd JE; Duggal P; Armanios M
    J Med Genet; 2011 May; 48(5):327-33. PubMed ID: 21415081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita.
    Yoon A; Peng G; Brandenburger Y; Zollo O; Xu W; Rego E; Ruggero D
    Science; 2006 May; 312(5775):902-6. PubMed ID: 16690864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human ribosomes from cells with reduced dyskerin levels are intrinsically altered in translation.
    Penzo M; Rocchi L; Brugiere S; Carnicelli D; Onofrillo C; Couté Y; Brigotti M; Montanaro L
    FASEB J; 2015 Aug; 29(8):3472-82. PubMed ID: 25934701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyskeratosis congenita.
    Handley TP; McCaul JA; Ogden GR
    Oral Oncol; 2006 Apr; 42(4):331-6. PubMed ID: 16140563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSE4, a Small Dyskerin- and GSE24.2-Related Peptide, Induces Telomerase Activity, Cell Proliferation and Reduces DNA Damage, Oxidative Stress and Cell Senescence in Dyskerin Mutant Cells.
    Iarriccio L; Manguán-García C; Pintado-Berninches L; Mancheño JM; Molina A; Perona R; Sastre L
    PLoS One; 2015; 10(11):e0142980. PubMed ID: 26571381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.